Author

A. K. Bajpai

Primary ORCID profile (0000-0002-5645-2466 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

A. K. BajpaiiD1 paper · Indian Institute of Technology Kanpur

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

K. K. Acharya· 2 shared S. Davuluri· 2 shared A. D. Robinson· 1 shared A. S. Guru· 1 shared B. V. S. K. Chakravarthi· 1 shared C. D. Willey· 1 shared D. K. Crossman· 1 shared D. L. Della Manna· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. K. Acharya

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypes

A. K. Bajpai, S. Davuluri, K. Thirumurugan, K. K. Acharya

This study performs a meta-analysis of transcriptomic data to identify subtype-specific candidate genes in breast cancer and suggests potential therapeutic targets.

bioRxiv · Aug 4, 2021 · PreprintCancer Biology

Therapeutically actionable PAK4 is amplified, overexpressed and involved in bladder cancer progression

D. S. Chandrashekar, B. V. S. K. Chakravarthi, A. D. Robinson, J. C. Anderson, S. Agarwal, S. A. Hodigere Balasubramanya, M.-L. Eich, A. K. Bajpai, S. Davuluri, M. S. Guru, A. S. Guru, G. Naik, D. L. Della Manna, K. K. Acharya, S. Carskadon, , S. Varambally

This study identifies PAK4 amplification and overexpression in bladder cancer and shows PAK4 inhibition reduces tumor growth, with potential for combination therapy.

bioRxiv · Aug 20, 2019Cancer Biology